Targeting viruses in their phase
- PMID: 34262155
- PMCID: PMC8278171
- DOI: 10.1038/s41580-021-00400-7
Targeting viruses in their phase
Abstract
The pathogenicity of SARS-CoV-2 and respiratory syncytial virus (RSV) involves mechanisms of liquid–liquid phase separation, which can be explored as targets for new antiviral therapeutics.
Comment on
-
A condensate-hardening drug blocks RSV replication in vivo.Nature. 2021 Jul;595(7868):596-599. doi: 10.1038/s41586-021-03703-z. Epub 2021 Jul 7. Nature. 2021. PMID: 34234347
-
Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.Nat Cell Biol. 2021 Jul;23(7):718-732. doi: 10.1038/s41556-021-00710-0. Epub 2021 Jul 8. Nat Cell Biol. 2021. PMID: 34239064
References
Original articles
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous